IBDEI0VS ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15444,0)
 ;;=584.9^^81^944^2
 ;;^UTILITY(U,$J,358.3,15444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15444,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,15444,1,5,0)
 ;;=5^Acute Renal Failure
 ;;^UTILITY(U,$J,358.3,15444,2)
 ;;=^67114
 ;;^UTILITY(U,$J,358.3,15445,0)
 ;;=583.9^^81^944^19
 ;;^UTILITY(U,$J,358.3,15445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15445,1,4,0)
 ;;=4^583.9
 ;;^UTILITY(U,$J,358.3,15445,1,5,0)
 ;;=5^Glomerulonephritis
 ;;^UTILITY(U,$J,358.3,15445,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,15446,0)
 ;;=403.90^^81^944^51
 ;;^UTILITY(U,$J,358.3,15446,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15446,1,4,0)
 ;;=4^403.90
 ;;^UTILITY(U,$J,358.3,15446,1,5,0)
 ;;=5^Renal Insufficiency with Hypertension (CRI and HTN)
 ;;^UTILITY(U,$J,358.3,15446,2)
 ;;=Renal Insufficiency with Hypertension (CRI and HTN)^269609
 ;;^UTILITY(U,$J,358.3,15447,0)
 ;;=593.9^^81^944^9
 ;;^UTILITY(U,$J,358.3,15447,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15447,1,4,0)
 ;;=4^593.9
 ;;^UTILITY(U,$J,358.3,15447,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,15447,2)
 ;;=Chronic Renal Insufficiency^123849
 ;;^UTILITY(U,$J,358.3,15448,0)
 ;;=581.9^^81^944^37
 ;;^UTILITY(U,$J,358.3,15448,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15448,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,15448,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,15448,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,15449,0)
 ;;=753.12^^81^944^43
 ;;^UTILITY(U,$J,358.3,15449,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15449,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,15449,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,15449,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,15450,0)
 ;;=791.0^^81^944^45
 ;;^UTILITY(U,$J,358.3,15450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15450,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,15450,1,5,0)
 ;;=5^Proteinuria
 ;;^UTILITY(U,$J,358.3,15450,2)
 ;;=Proteinuria^99873
 ;;^UTILITY(U,$J,358.3,15451,0)
 ;;=791.9^^81^944^48
 ;;^UTILITY(U,$J,358.3,15451,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15451,1,4,0)
 ;;=4^791.9
 ;;^UTILITY(U,$J,358.3,15451,1,5,0)
 ;;=5^Pyuria
 ;;^UTILITY(U,$J,358.3,15451,2)
 ;;=^273408
 ;;^UTILITY(U,$J,358.3,15452,0)
 ;;=592.0^^81^944^49
 ;;^UTILITY(U,$J,358.3,15452,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15452,1,4,0)
 ;;=4^592.0
 ;;^UTILITY(U,$J,358.3,15452,1,5,0)
 ;;=5^Renal Calculi
 ;;^UTILITY(U,$J,358.3,15452,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,15453,0)
 ;;=403.91^^81^944^50
 ;;^UTILITY(U,$J,358.3,15453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15453,1,4,0)
 ;;=4^403.91
 ;;^UTILITY(U,$J,358.3,15453,1,5,0)
 ;;=5^Renal Failure, Chronic Hypertensive
 ;;^UTILITY(U,$J,358.3,15453,2)
 ;;=^269610
 ;;^UTILITY(U,$J,358.3,15454,0)
 ;;=586.^^81^944^53
 ;;^UTILITY(U,$J,358.3,15454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15454,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,15454,1,5,0)
 ;;=5^Uremia
 ;;^UTILITY(U,$J,358.3,15454,2)
 ;;=Uremia^104733
 ;;^UTILITY(U,$J,358.3,15455,0)
 ;;=599.0^^81^944^65
 ;;^UTILITY(U,$J,358.3,15455,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15455,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,15455,1,5,0)
 ;;=5^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,15455,2)
 ;;=Urinary Tract Infection^124436
 ;;^UTILITY(U,$J,358.3,15456,0)
 ;;=275.42^^81^944^28
 ;;^UTILITY(U,$J,358.3,15456,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15456,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,15456,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,15456,2)
 ;;=Hypercalcemia^59932
 ;;^UTILITY(U,$J,358.3,15457,0)
 ;;=275.41^^81^944^31
 ;;^UTILITY(U,$J,358.3,15457,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0VS
